Becton Dickinson Profit Margin 2006-2018 | BDX

Current and historical gross margin, operating margin and net profit margin for Becton Dickinson (BDX) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Becton Dickinson net profit margin as of December 31, 2018 is 5.69%.
Becton Dickinson Annual Profit Margins
Becton Dickinson Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $61.357B $15.983B
Becton, Dickinson & Company is a global medical technology company that is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. BD leads in patient and health care worker safety and the technologies that enable medical research and clinical laboratories. The company provides innovative solutions that help advance medical research and genomics, enhance the diagnosis of infectious disease and cancer, improve medication management, promote infection prevention, equip surgical and interventional procedures, and support the management of diabetes. The company partners with organizations around the world to address some of the most challenging global health issues.
Stock Name Country Market Cap PE Ratio
Align Technology (ALGN) United States $23.685B 60.30
McKesson (MCK) United States $22.098B 8.60
AmerisourceBergen (ABC) United States $15.500B 11.24
Laboratory Of America Holdings (LH) United States $14.929B 13.73
Cooper (COO) United States $14.158B 24.70
Cardinal Health (CAH) United States $13.733B 9.25
DENTSPLY SIRONA (XRAY) United States $11.134B 24.76
Henry Schein (HSIC) United States $9.456B 15.28
West Pharmaceutical Services (WST) United States $8.495B 41.00
Merit Medical Systems (MMSI) United States $3.255B 33.83
CONMED (CNMD) United States $2.280B 37.05
Patterson (PDCO) United States $2.051B 16.20
Atrion (ATRI) United States $1.614B 47.36
STAAR Surgical (STAA) United States $1.363B 114.18
Antares Pharma (ATRS) United States $0.453B 0.00
Invacare (IVC) United States $0.244B 0.00
Lifevantage (LFVN) United States $0.171B 23.02
Pro-Dex (PDEX) United States $0.066B 30.13
Endologix (ELGX) United States $0.063B 0.00
Biolase (BIOL) United States $0.047B 0.00
Retractable Technologies (RVP) United States $0.023B 0.00
Milestone Scientific (MLSS) United States $0.017B 0.00